← Back to All US Stocks

RadNet, Inc. (RDNT) Stock Fundamental Analysis & AI Rating 2026

RDNT Nasdaq Services-Medical Laboratories DE CIK: 0000790526
Updated This Month • Analysis: May 13, 2026 • SEC Data: 2026-03-31
Combined AI Rating
SELL
74% Confidence
AGREEMENT
SELL
78% Conf
HOLD
70% Conf

📊 RDNT Key Takeaways

Revenue: $575.6M
Net Margin: -5.8%
Free Cash Flow: $4.8M
Current Ratio: 1.17x
Debt/Equity: 1.01x
EPS: $-0.43
AI Rating: SELL with 78% confidence
RadNet, Inc. (RDNT) receives a SELL rating with 74% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $575.6M, net profit margin of -5.8%, and return on equity (ROE) of -3.1%, RadNet, Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete RDNT stock analysis for 2026.

Is RadNet, Inc. (RDNT) a Good Investment?

Claude

RadNet is growing revenue at 11.5% YoY but experiencing severe profitability headwinds with deepening net losses (-56.1% YoY) and negative operating margins. The company cannot cover interest expenses from operations (negative interest coverage of -1.4x) while carrying 1.1B in long-term debt, creating unsustainable financial stress despite a reasonable cash position of 455.3M.

ChatGPT

RadNet shows solid fundamental growth with 11.5% revenue expansion and strong free cash flow generation supported by ample liquidity. However, thin operating profitability, negative GAAP earnings, and sub-1.0x interest coverage temper the outlook until margins improve and debt service coverage strengthens.

Why Buy RadNet, Inc. Stock? RDNT Key Strengths

Claude
  • + Revenue growth of 11.5% YoY indicates market demand and operational scale expansion
  • + Positive operating cash flow of 79.0M demonstrates underlying business generates cash despite accounting losses
  • + Strong cash balance of 455.3M provides short-term liquidity buffer for debt service and operations
ChatGPT
  • + Double-digit revenue growth (+11.5% YoY)
  • + Robust cash generation (OCF $299M, 11% FCF margin)
  • + Strong liquidity with $767M cash and 1.76x current ratio

RDNT Stock Risks: RadNet, Inc. Investment Risks

Claude
  • ! Operating losses of -23.9M and deteriorating net losses (-56.1% YoY) show profitability is worsening, not improving
  • ! Negative interest coverage ratio (-1.4x) indicates company cannot service 1.1B debt from operating earnings, creating refinancing risk
  • ! Minimal free cash flow margin of 0.8% with capex consuming 74.2M leaves almost no room for error or discretionary deployment
ChatGPT
  • ! Negative net income and slim 3.0% operating margin
  • ! Weak interest coverage (0.9x) indicating debt cost pressure
  • ! Cost growth outpacing revenue (net income down YoY)

Key Metrics to Watch

Claude
  • * Operating margin recovery trajectory - must trend toward positive territory
  • * Interest coverage ratio - critical threshold is achieving positive coverage to service 1.1B debt sustainably
  • * Free cash flow sustainability - OCF must grow faster than capex requirements to improve FCF margin above 5%
ChatGPT
  • * Interest coverage
  • * Operating margin

RadNet, Inc. (RDNT) Financial Metrics & Key Ratios

Revenue
$575.6M
Net Income
$-33.5M
EPS (Diluted)
$-0.43
Free Cash Flow
$4.8M
Total Assets
$3.9B
Cash Position
$455.3M

💡 AI Analyst Insight

The relatively thin 0.8% FCF margin may limit capital allocation flexibility.

RDNT Profit Margin, ROE & Profitability Analysis

Gross Margin N/A
Operating Margin -4.2%
Net Margin -5.8%
ROE -3.1%
ROA -0.9%
FCF Margin 0.8%

RDNT vs Healthcare Sector: How RadNet, Inc. Compares

How RadNet, Inc. compares to Healthcare sector averages

Net Margin
RDNT -5.8%
vs
Sector Avg 12.0%
RDNT Sector
ROE
RDNT -3.1%
vs
Sector Avg 15.0%
RDNT Sector
Current Ratio
RDNT 1.2x
vs
Sector Avg 2.0x
RDNT Sector
Debt/Equity
RDNT 1.0x
vs
Sector Avg 0.6x
RDNT Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is RadNet, Inc. Stock Overvalued? RDNT Valuation Analysis 2026

Based on fundamental analysis, RadNet, Inc. shows some fundamental concerns relative to the Healthcare sector in 2026.

Return on Equity
-3.1%
Sector avg: 15%
Net Profit Margin
-5.8%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
1.01x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

RadNet, Inc. Balance Sheet: RDNT Debt, Cash & Liquidity

Current Ratio
1.17x
Quick Ratio
1.17x
Debt/Equity
1.01x
Debt/Assets
65.2%
Interest Coverage
-1.35x
Long-term Debt
$1.1B

RDNT Revenue & Earnings Growth: 5-Year Financial Trend

RDNT 5-year financial data: Year 2021: Revenue $1.3B, Net Income $14.8M, EPS $0.29. Year 2022: Revenue $1.4B, Net Income -$14.8M, EPS $-0.29. Year 2023: Revenue $1.6B, Net Income $24.7M, EPS $0.46. Year 2024: Revenue $1.8B, Net Income $10.7M, EPS $0.17. Year 2025: Revenue $2.0B, Net Income $3.0M, EPS $0.05.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: RadNet, Inc.'s revenue has grown significantly by 55% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.05 reflects profitable operations.

RDNT Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
0.8%
Free cash flow / Revenue

RDNT Quarterly Earnings & Performance

Quarterly financial performance data for RadNet, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q1 2026 $471.4M -$33.5M $-0.43
Q3 2025 $461.1M -$2.6M $-0.04
Q2 2025 $459.7M -$3.0M $-0.04
Q1 2025 $431.7M -$2.8M $-0.04
Q3 2024 $402.0M -$2.6M $-0.04
Q2 2024 $403.7M -$3.0M $-0.04
Q1 2024 $390.6M -$2.8M $-0.04
Q3 2023 $350.0M $668.0K $0.01

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

RadNet, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
$79.0M
Cash generated from operations
Capital Expenditures
$74.2M
Investment in assets
Dividends Paid
$759.0K
Returned to shareholders

RDNT SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for RadNet, Inc. (CIK: 0000790526)

📋 Recent SEC Filings

Date Form Document Action
May 11, 2026 10-Q rdnt-20260331.htm View →
May 11, 2026 8-K radnet_8k.htm View →
May 6, 2026 4 xslF345X06/ownership.xml View →
Apr 20, 2026 DEF 14A radnet_idef14a.htm View →
Mar 23, 2026 4 xslF345X06/ownership.xml View →

Frequently Asked Questions about RDNT

What is the AI rating for RDNT?

RadNet, Inc. (RDNT) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 74% combined confidence, based on fundamental analysis of SEC EDGAR filings.

What are RDNT's key strengths?

Claude: Revenue growth of 11.5% YoY indicates market demand and operational scale expansion. Positive operating cash flow of 79.0M demonstrates underlying business generates cash despite accounting losses. ChatGPT: Double-digit revenue growth (+11.5% YoY). Robust cash generation (OCF $299M, 11% FCF margin).

What are the risks of investing in RDNT?

Claude: Operating losses of -23.9M and deteriorating net losses (-56.1% YoY) show profitability is worsening, not improving. Negative interest coverage ratio (-1.4x) indicates company cannot service 1.1B debt from operating earnings, creating refinancing risk. ChatGPT: Negative net income and slim 3.0% operating margin. Weak interest coverage (0.9x) indicating debt cost pressure.

What is RDNT's revenue and growth?

RadNet, Inc. reported revenue of $575.6M.

Does RDNT pay dividends?

RadNet, Inc. pays dividends, with $0.8M distributed to shareholders in the trailing twelve months.

Where can I find RDNT SEC filings?

Official SEC filings for RadNet, Inc. (CIK: 0000790526) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is RDNT's EPS?

RadNet, Inc. has a diluted EPS of $-0.43.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is RDNT a good stock to buy right now?

Based on our AI fundamental analysis in May 2026, RadNet, Inc. has a SELL rating with 74% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is RDNT stock overvalued or undervalued?

Valuation metrics for RDNT: ROE of -3.1% (sector avg: 15%), net margin of -5.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy RDNT stock in 2026?

Our dual AI analysis gives RadNet, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is RDNT's free cash flow?

RadNet, Inc.'s operating cash flow is $79.0M, with capital expenditures of $74.2M. FCF margin is 0.8%.

How does RDNT compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -5.8% (avg: 12%), ROE -3.1% (avg: 15%), current ratio 1.17 (avg: 2).

Top Rated Stocks
AAPL 92% MSFT 92% FAST 92% ANET 88% RDDT 88% KNSL 88% MGRE 88% FIZZ 88% DECK 87% NVDA 87%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: May 13, 2026 | Data as of: 2026-03-31 | Powered by Claude AI